AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
INITIAL MANAGEMENT OF PRIMARY MEDIASTINAL SEMINOMA - RADIOTHERAPY OR CISPLATIN-BASED CHEMOTHERAPY
Authors: FIZAZI K CULINE S DROZ JP TERRIERLACOMBE MJ THEODORE C WIBAULT P RIXE O RUFFIE P LECHEVALIER T
Citation: K. Fizazi et al., INITIAL MANAGEMENT OF PRIMARY MEDIASTINAL SEMINOMA - RADIOTHERAPY OR CISPLATIN-BASED CHEMOTHERAPY, European journal of cancer, 34(3), 1998, pp. 347-352
TREATMENT OF POORLY DIFFERENTIATED NEUROENDOCRINE TUMORS (PDNET) WITHETOPOSIDE (VP16) AND CISPLATIN (CDDP)
Authors: MITRY E BAUDIN E DUCREUX M SABOURIN JC YAKENDJI K RUFFIE P LASSER P SCHLUMBERGER M ROUGIER P
Citation: E. Mitry et al., TREATMENT OF POORLY DIFFERENTIATED NEUROENDOCRINE TUMORS (PDNET) WITHETOPOSIDE (VP16) AND CISPLATIN (CDDP), Annals of oncology, 9, 1998, pp. 226-226
A RANDOMIZED STUDY OF TIMING FOR WHOLE-BRAIN RADIOTHERAPY (WBRT) WITHCONCURRENT CHEMOTHERAPY (CT) IN INOPERABLE BRAIN METASTASIS (BM) OF NON-SMALL-CELL LUNG-CANCER (NSCLC)
Authors: THOMAS P ROBINET G BRETON JL REBATTU P RUFFIE P DEBIEUVRE D AMMATURO MV MARICHY C DELHOUME JY GRELLE K
Citation: P. Thomas et al., A RANDOMIZED STUDY OF TIMING FOR WHOLE-BRAIN RADIOTHERAPY (WBRT) WITHCONCURRENT CHEMOTHERAPY (CT) IN INOPERABLE BRAIN METASTASIS (BM) OF NON-SMALL-CELL LUNG-CANCER (NSCLC), Annals of oncology, 9, 1998, pp. 401-401
PHARMACOKINETIC (PK) OF TOMUDEX((R)) (RALTITREXED) (T) AND OXALIPLATIN (0) COMBINATION - PRELIMINARY-RESULTS OF AN ONGOING PHASE-I STUDY
Authors: FIZAZI K BONNAY M FOURCAULT D RUFFIE P COUTURAS O SMITH M GOMENI R FANDI A ARMAND JP
Citation: K. Fizazi et al., PHARMACOKINETIC (PK) OF TOMUDEX((R)) (RALTITREXED) (T) AND OXALIPLATIN (0) COMBINATION - PRELIMINARY-RESULTS OF AN ONGOING PHASE-I STUDY, Annals of oncology, 9, 1998, pp. 612-612
AN ONGOING PHASE-I TRIAL OF TOMUDEX(R) (T) IN COMBINATION WITH OXALIPLATIN (L-OHP) IN ADVANCED SOLID TUMORS - A PROMISING AND ACTIVE COMBINATION
Authors: FIZAZI K BAUDIN E RUFFIE P DUCREUX M SORIA JC LECHEVALIER T BONNAY M COUTURAS O FANDI A ARMAND JP
Citation: K. Fizazi et al., AN ONGOING PHASE-I TRIAL OF TOMUDEX(R) (T) IN COMBINATION WITH OXALIPLATIN (L-OHP) IN ADVANCED SOLID TUMORS - A PROMISING AND ACTIVE COMBINATION, Annals of oncology, 9, 1998, pp. 460-460
PRIMARY MEDIASTINAL NONSEMINOMATOUS GERM-CELL TUMORS - RESULTS OF MODERN THERAPY INCLUDING CISPLATIN-BASED CHEMOTHERAPY
Authors: FIZAZI K CULINE S DROZ JP KRAMAR A THEODORE C RUFFIE P LECHEVALIER T
Citation: K. Fizazi et al., PRIMARY MEDIASTINAL NONSEMINOMATOUS GERM-CELL TUMORS - RESULTS OF MODERN THERAPY INCLUDING CISPLATIN-BASED CHEMOTHERAPY, Journal of clinical oncology, 16(2), 1998, pp. 725-732
ALTERNATING RADIOTHERAPY AND CHEMOTHERAPY IN LIMITED DISEASE SMALL-CELL LUNG-CANCER
Authors: LEPECHOUX C ARRIAGADA R LECHEVALIER T TARAYRE M RUFFIE P BALDEYROU P BRETEL JJ PELLAECOSSET B HANZEN C MARTIN M DUROUX P
Citation: C. Lepechoux et al., ALTERNATING RADIOTHERAPY AND CHEMOTHERAPY IN LIMITED DISEASE SMALL-CELL LUNG-CANCER, Radiotherapy and oncology, 46(3), 1998, pp. 257-261
STANDARDS, OPTIONS AND RECOMMENDATIONS (SOR) FOR CLINICAL CARE OF MALIGNANT PLEURAL MESOTHELIOMA
Authors: RUFFIE P LEHMANN M GALATEAUSALLE F LAGRANGE JL PAIRON JC
Citation: P. Ruffie et al., STANDARDS, OPTIONS AND RECOMMENDATIONS (SOR) FOR CLINICAL CARE OF MALIGNANT PLEURAL MESOTHELIOMA, Bulletin du cancer, 85(6), 1998, pp. 545-561
NEURON-SPECIFIC ENOLASE AND CHROMOGRANIN-A AS MARKERS OF NEUROENDOCRINE TUMORS
Authors: BAUDIN E GIGLIOTTI A DUCREUX R ROPERS J COMOY E SABOURIN JC BIDART JM CAILLEUX AF BONACCI R RUFFIE P SCHLUMBERGER M
Citation: E. Baudin et al., NEURON-SPECIFIC ENOLASE AND CHROMOGRANIN-A AS MARKERS OF NEUROENDOCRINE TUMORS, British Journal of Cancer, 78(8), 1998, pp. 1102-1107
NEOADJUVANT CISPLATIN-VINDESINE VINORELBINE BASED COMBINATION CHEMOTHERAPY (CT) FOR STAGE-III NONSMALL CELL LUNG-CANCER (NSCLC)/
Authors: CIULEANU TE CHAHINE A TODOR N MONNET I AZLI N VOISIN S RIGGI M SALTIEL JC ARMAND JP RUFFIE P DECREMOUX H CVITKOVIC E
Citation: Te. Ciuleanu et al., NEOADJUVANT CISPLATIN-VINDESINE VINORELBINE BASED COMBINATION CHEMOTHERAPY (CT) FOR STAGE-III NONSMALL CELL LUNG-CANCER (NSCLC)/, European journal of cancer, 33, 1997, pp. 1056-1056
HIGHER DOSES OF ALPHA-INTERFERON DO NOT INCREASE THE ACTIVITY OF THE WEEKLY CISPLATIN-INTERFERON COMBINATION IN ADVANCED MALIGNANT MESOTHELIOMA
Authors: TRANDAFIR L RUFFIE P BOREL C MONNET I SOULIE P ADAMS D CVITKOVIC E ARMAND JP
Citation: L. Trandafir et al., HIGHER DOSES OF ALPHA-INTERFERON DO NOT INCREASE THE ACTIVITY OF THE WEEKLY CISPLATIN-INTERFERON COMBINATION IN ADVANCED MALIGNANT MESOTHELIOMA, European journal of cancer, 33(11), 1997, pp. 1900-1902
PRIMARY MEDIASTINAL NONSEMINOMATOUS GERM- CELL TUMORS - FROM CLINICS TO BIOLOGY
Authors: FIZAZI K CULINE S DROZ JP LECHEVALIER T RUFFIE P THEODORE C
Citation: K. Fizazi et al., PRIMARY MEDIASTINAL NONSEMINOMATOUS GERM- CELL TUMORS - FROM CLINICS TO BIOLOGY, Bulletin du cancer, 84(3), 1997, pp. 313-327
SURGERY FOR LUNG METASTASES FROM COLORECTAL-CANCER - ANALYSIS OF PROGNOSTIC FACTORS
Authors: GIRARD P DUCREUX M BALDEYROU P ROUGIER P LECHEVALIER T BOUGARAN J LASSER P GAYET B RUFFIE P GRUNENWALD D
Citation: P. Girard et al., SURGERY FOR LUNG METASTASES FROM COLORECTAL-CANCER - ANALYSIS OF PROGNOSTIC FACTORS, Journal of clinical oncology, 14(7), 1996, pp. 2047-2053
COMBINED SYSTEMIC CHEMOIMMUNOTHERAPY IN ADVANCED DIFFUSE MALIGNANT MESOTHELIOMA - REPORT OF A PHASE I-II STUDY OF WEEKLY CISPLATIN INTERFERON ALFA-2A
Authors: SOULIE P RUFFIE P TRANDAFIR L MONNET I TARDIVON A TERRIER P CVITKOVIC E LECHEVALIER T ARMAND JP
Citation: P. Soulie et al., COMBINED SYSTEMIC CHEMOIMMUNOTHERAPY IN ADVANCED DIFFUSE MALIGNANT MESOTHELIOMA - REPORT OF A PHASE I-II STUDY OF WEEKLY CISPLATIN INTERFERON ALFA-2A, Journal of clinical oncology, 14(3), 1996, pp. 878-885
CONCURRENT CISPLATIN-VINDESINE AND HYPERFRACTIONATED THORACIC RADIOTHERAPY IN LOCALLY ADVANCED NONSMALL CELL LUNG-CANCER
Authors: LEPECHOUX C ARRIAGADA R LECHEVALIER T BRETEL JJ COSSET BP RUFFIE P BALDEYROU P GRUNENWALD D
Citation: C. Lepechoux et al., CONCURRENT CISPLATIN-VINDESINE AND HYPERFRACTIONATED THORACIC RADIOTHERAPY IN LOCALLY ADVANCED NONSMALL CELL LUNG-CANCER, International journal of radiation oncology, biology, physics, 35(3), 1996, pp. 519-525
RANDOMIZED STUDY OF NAVELBINE(R) AND CISP LATIN VERSUS VINDESINE AND CISPLATIN VERSUS NAVELBINE(R) ALONE IN 612 PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)
Authors: LECHEVALIER T BRISGAND D PUJOL JL DOUILLARD JY MONNIER A RIVIERE A CHOMY P LEGROUMELLEC A RUFFIE P GOTTFRIED M GASPARD MH CHEVREAU C ALBEROLA V CIGOLARI S BESSON F MARTINEZ A BESENVAL M BERTHAUD P TURSZ T
Citation: T. Lechevalier et al., RANDOMIZED STUDY OF NAVELBINE(R) AND CISP LATIN VERSUS VINDESINE AND CISPLATIN VERSUS NAVELBINE(R) ALONE IN 612 PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC), Bulletin du cancer, 83(5), 1996, pp. 385-394
ENDOBRONCHIAL HDR BRACHYTHERAPY - A CURATIVE APPROACH FOR VERY LIMITED NON-SMALL-CELL CARCINOMAS
Authors: BALDEYROU P MARSIGLIA H LARTIGAU E ALBANO M DELAPIERRE M LECHEVALIER T RUFFIE P ARRIAGADA R GERBAULET A
Citation: P. Baldeyrou et al., ENDOBRONCHIAL HDR BRACHYTHERAPY - A CURATIVE APPROACH FOR VERY LIMITED NON-SMALL-CELL CARCINOMAS, European journal of cancer, 31A, 1995, pp. 196-196
PULMONARY METASTASES (PM) FROM COLORECTAL-CANCER (CRC) TREATED BY SURGICAL RESECTION - PROGNOSTIC FACTOR-ANALYSIS
Authors: DUCREUX M GIRARD P BALDEYROU P ROUGIER P LECHEVALLIER T RUFFIE P GRUNENWALD D
Citation: M. Ducreux et al., PULMONARY METASTASES (PM) FROM COLORECTAL-CANCER (CRC) TREATED BY SURGICAL RESECTION - PROGNOSTIC FACTOR-ANALYSIS, European journal of cancer, 31A, 1995, pp. 725-725
A PROPOSED NEW INTERNATIONAL TNM STAGING SYSTEM FOR MALIGNANT PLEURALMESOTHELIOMA
Authors: AISNER J BOUTIN C BUTCHART EG CHAHINIAN P FABER LP HEELAN R MATTSON K PASS HI PATZ EF ROBINSON B RUSCH VW TAMMILEHTO L VOGELZANG NJ AISNER S ANTMAN KH BELANI CP BIGNON J BRODIN O FEINS R GINSBERG R HAMMAR S HERNDON J HILLARDEL G ILSON D KELLER S KELSEN D KRASNA M MAASILTA P MONNET I ROGGLI VL RUFFIE P SALMINEN U SALTZ L STRAUSS G VIALLAT JR VONBULTZINGSLOWEN F
Citation: J. Aisner et al., A PROPOSED NEW INTERNATIONAL TNM STAGING SYSTEM FOR MALIGNANT PLEURALMESOTHELIOMA, Chest, 108(4), 1995, pp. 1122-1128
STANDARDS, OPTIONS AND GUIDELINES FOR THE USE OF ANTIEMETICS IN ONCOLOGY
Authors: RIVIERE A BECKENDORF V BONNETERRE J BUI NB CATIMEL G CUPISSOL D FARGEOT P HECQUET B KRAKOWSKI I MADELAINECHAMBRIN I MIHURA J ROCHE H RUFFIE P SCHNEIDER M PHILIP T
Citation: A. Riviere et al., STANDARDS, OPTIONS AND GUIDELINES FOR THE USE OF ANTIEMETICS IN ONCOLOGY, Bulletin du cancer, 82, 1995, pp. 453-485
SUPER-HIGH-RISK GERM-CELL TUMORS - A CLINICAL ENTITY - REPORT OF 11 CASES
Authors: MORANRIBON A DROZ JP KATTAN J LECLERCQ B GHOSN M COUANET D OSTRONOFF M CULINE S MISSET B ESCUDIER B RUFFIE P NITENBERG G
Citation: A. Moranribon et al., SUPER-HIGH-RISK GERM-CELL TUMORS - A CLINICAL ENTITY - REPORT OF 11 CASES, Supportive care in cancer, 2(4), 1994, pp. 253-258
RANDOMIZED STUDY OF VINORELBINE AND CISPLATIN VERSUS VINDESINE AND CISPLATIN VERSUS VINORELBINE ALONE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - RESULTS OF A EUROPEAN MULTICENTER TRIAL INCLUDING 612 PATIENTS
Authors: LECHEVALIER T BRISGAND D DOUILLARD JY PUJOL JL ALBEROLA V MONNIER A RIVIERE A LIANES P CHOMY P CIGOLARI S GOTTFRIED M RUFFIE P PANIZO A GASPARD MH RAVAIOLI A BESENVAL M BESSEN F MARTINEZ A BERTHAUD P TURSZ T
Citation: T. Lechevalier et al., RANDOMIZED STUDY OF VINORELBINE AND CISPLATIN VERSUS VINDESINE AND CISPLATIN VERSUS VINORELBINE ALONE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - RESULTS OF A EUROPEAN MULTICENTER TRIAL INCLUDING 612 PATIENTS, Journal of clinical oncology, 12(2), 1994, pp. 360-367
TRIANGULAR TEST AND RANDOMIZED TRIALS - PRACTICAL PROBLEMS IN A SMALLLUNG-CANCER TRIAL
Authors: PIGNON JP TARAYRE M AUQUIER A ARRIAGADA R LECHEVALIER T RUFFIE P RIVIERE A MONNET I CHOMY P TUCHAIS C
Citation: Jp. Pignon et al., TRIANGULAR TEST AND RANDOMIZED TRIALS - PRACTICAL PROBLEMS IN A SMALLLUNG-CANCER TRIAL, Statistics in medicine, 13(13-14), 1994, pp. 1415-1421
SMALL-CELL LUNG-CANCER - PATIENTS SURVIVING LONGER THAN 30 MONTHS
Authors: MORO D JACOULET P QUOIX E RANFAING E BRAMBILLA E CAPRON F LAGRANGE JL MILLERON B LEBEAU B RUFFIE P RIVIERE A BLANCHON F GERAADS A DEPIERRE A
Citation: D. Moro et al., SMALL-CELL LUNG-CANCER - PATIENTS SURVIVING LONGER THAN 30 MONTHS, Anticancer research, 14(1B), 1994, pp. 301-304
DOSE INTENSITY IN LUNG-CANCER TREATMENT
Authors: COX J BALL D BELANI C CHOI N GRALLA R HALLE J KOMAKI R LECHEVALIER T OHNOSHI T QUOIX E RUFFIE P SHAW E SOUHAMI R TURRISI A
Citation: J. Cox et al., DOSE INTENSITY IN LUNG-CANCER TREATMENT, Lung cancer, 10, 1994, pp. 190000011-190000013
Risultati: 1-25 | 26-30